Improved Antiviral Therapy Outcomes Tied to Lower Blood Lower Levels of SARS-CoV-2 RNA and Nucleocapsid Antigen
The following is a summary of “SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir,” published in the April 2024 issue of Infectious Disease by Singh et al. Researchers...